July 6, 2017 / 12:32 PM / 20 days ago

Slovenian Krka sees H1 group net up by 31 pct

1 Min Read

LJUBLJANA, July 6 (Reuters) - Group net profit for Slovenia's generic drug producer Krka rose by 31 percent to 91.7 million euros ($104.4 million) in the first half of the year, according to an initial estimate of the figures, Krka said in a statement on Thursday.

It said sales rose by 8.5 percent to 655 million euros, adding final H1 figures would be released on July 27. ($1 = 0.8781 euros) (Reporting By Marja Novak; Editing by Keith Weir)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below